118 related articles for article (PubMed ID: 11242654)
1. [A trial with single-agent vinorelbine in taxane-resistant non-small cell lung cancer].
Miyata J; Sano T; Bando H
Gan To Kagaku Ryoho; 2001 Feb; 28(2):239-42. PubMed ID: 11242654
[TBL] [Abstract][Full Text] [Related]
2. Effect of vinorelbine monotherapy in taxane-treated patients with advanced non-small-cell lung cancer.
Miyata J; Sano T; Bando H
Med Oncol; 2002; 19(1):11-4. PubMed ID: 12025886
[TBL] [Abstract][Full Text] [Related]
3. [Properties of antitumor activity of vinorelbine tartrate, a new vinca alkaloid antitumor agent].
Kanazawa J; Morimoto M; Ohmori K
Nihon Yakurigaku Zasshi; 2000 Oct; 116(4):215-23. PubMed ID: 11084918
[TBL] [Abstract][Full Text] [Related]
4. Salvage therapy with vinorelbine in advanced non-small-cell lung cancer: a retrospective review of the Fox Chase Cancer Center experience and a review of the literature.
Devlin JG; Langer CJ
Clin Lung Cancer; 2007 Mar; 8(5):319-26. PubMed ID: 17562231
[TBL] [Abstract][Full Text] [Related]
5. [New cytostatics in the therapy of non-small cell bronchial carcinoma].
Serke M; Schönfeld N; Loddenkemper R
Pneumologie; 1998 Jun; 52(6):333-7. PubMed ID: 9715648
[No Abstract] [Full Text] [Related]
6. Single-agent vinorelbine in the treatment of non-small cell lung cancer.
Wozniak AJ
Semin Oncol; 1999 Oct; 26(5 Suppl 16):62-6; discussion 71-2. PubMed ID: 10585010
[TBL] [Abstract][Full Text] [Related]
7. Significant activity of single agent vinorelbine against small-cell cancer of the bladder as second line chemotherapy: a case series and review of the literature.
June RR; Dougherty DW; Reese CT; Harpster LE; Hoffman SL; Drabick JJ
Urol Oncol; 2012; 30(2):192-5. PubMed ID: 20363163
[TBL] [Abstract][Full Text] [Related]
8. New drugs in non-small cell lung cancer. An overview.
Giaccone G
Lung Cancer; 1995 Apr; 12 Suppl 1():S155-62. PubMed ID: 7551924
[TBL] [Abstract][Full Text] [Related]
9. Update: vinorelbine (navelbine) in non-small cell lung cancer.
Crawford J
Semin Oncol; 1996 Apr; 23(2 Suppl 5):2-7. PubMed ID: 8610232
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA
Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330
[TBL] [Abstract][Full Text] [Related]
11. Hsp27 may allow prediction of the response to single-agent vinorelbine chemotherapy in non-small cell lung cancer.
Berrieman HK; Cawkwell L; O'Kane SL; Smith L; Lind MJ
Oncol Rep; 2006 Jan; 15(1):283-6. PubMed ID: 16328069
[TBL] [Abstract][Full Text] [Related]
12. Acute respiratory failure caused by vinorelbine tartrate in a patient with non-small cell lung cancer.
Uoshima N; Yoshioka K; Tegoshi H; Wada S; Fujiwara Y; Satake N; Kasamatsu Y; Yokoho S
Intern Med; 2001 Aug; 40(8):779-82. PubMed ID: 11518124
[TBL] [Abstract][Full Text] [Related]
13. Failure of vinorelbine to produce responses in pretreated non-small cell lung cancer patients.
Pronzato P; Landucci M; Vaira F; Vigani A; Bertelli G
Anticancer Res; 1994; 14(3B):1413-5. PubMed ID: 8067715
[TBL] [Abstract][Full Text] [Related]
14. Vinorelbine for non-small cell lung cancer.
Piccirillo MC; Daniele G; Di Maio M; Bryce J; De Feo G; Del Giudice A; Perrone F; Morabito A
Expert Opin Drug Saf; 2010 May; 9(3):493-510. PubMed ID: 20350282
[TBL] [Abstract][Full Text] [Related]
15. Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancer.
Westeel V; Quoix E; Moro-Sibilot D; Mercier M; Breton JL; Debieuvre D; Richard P; Haller MA; Milleron B; Herman D; Level MC; Lebas FX; Puyraveau M; Depierre A;
J Natl Cancer Inst; 2005 Apr; 97(7):499-506. PubMed ID: 15812075
[TBL] [Abstract][Full Text] [Related]
16. [Clinical trials of vnorelbine in breast cancer--its scientific usefulness and development history until regulatory approval].
Tominaga T
Gan To Kagaku Ryoho; 2006 Apr; 33(4):541-7. PubMed ID: 16612169
[TBL] [Abstract][Full Text] [Related]
17. Management of elderly patients with lung cancer.
Ranson MR; White S; Thatcher N
Curr Oncol Rep; 2000 Jan; 2(1):90-5. PubMed ID: 11122829
[TBL] [Abstract][Full Text] [Related]
18. [Vinorelbine for non-small cell lung cancer].
Seto T
Nihon Rinsho; 2002 May; 60 Suppl 5():353-8. PubMed ID: 12101688
[No Abstract] [Full Text] [Related]
19. Expression of class III {beta}-tubulin is predictive of patient outcome in patients with non-small cell lung cancer receiving vinorelbine-based chemotherapy.
Sève P; Isaac S; Trédan O; Souquet PJ; Pachéco Y; Pérol M; Lafanéchère L; Penet A; Peiller EL; Dumontet C
Clin Cancer Res; 2005 Aug; 11(15):5481-6. PubMed ID: 16061864
[TBL] [Abstract][Full Text] [Related]
20. Docetaxel (Taxotere) and vinorelbine in the treatment of non-small cell lung cancer.
Georgoulias V; Kourousis C; Androulakis N; Kakolyris S; Papadakis E; Bouros D; Apostolopoulou F; Georgopoulou T; Agelidou M; Souglakos J; Halkiadakis G; Hatzidaki D
Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-9-S14-14. PubMed ID: 9335517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
